BAX-BAK Heterodimer As a Pharmacodynamic Biomarker of On-Target Drug Action of Mcl-1 Inhibitors to Evaluate In-Vivo Effectiveness.
Journal of clinical oncology(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of clinical oncology(2018)